Healthcare Focus Montserrat: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Montserrat.

Press releases published on November 12, 2026

4 hours ago

Immuneering to Collaborate with Astellas on Clinical Studies of Investigational CLDN18.2 Programs in Combination with Atebimetinib for Pancreatic Cancer Patients

Indeterminate GlobeNewswire

4 hours ago

Vor Bio Expands Strategic Partnership with RemeGen, Adding Next Generation, Long-Acting RC298 to BAFF/APRIL Franchise

Indeterminate GlobeNewswire

4 hours ago

MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth

Indeterminate GlobeNewswire

4 hours ago

Dyadic’s C1-Produced RSV and Malaria Antibodies Advance into Animal Studies Following Positive Independent Evaluations

Indeterminate GlobeNewswire

4 hours ago

Ascendis Pharma Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

4 hours ago

Generate Biomedicines Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

5 hours ago

Altimmune Announces Publication of IMPACT Phase 2b 48-Week Data in MASH in The Lancet Gastroenterology & Hepatology

Indeterminate GlobeNewswire

5 hours ago

NervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury

Indeterminate GlobeNewswire

5 hours ago

Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

5 hours ago

Alterity Therapeutics to Present at the Virtual Bell Potter Healthcare Conference

Indeterminate GlobeNewswire

5 hours ago

Maple Report: More than half of Canadian patients and families report being left without adequate updates while waiting for care

Indeterminate GlobeNewswire

5 hours ago

ProQR Announces Third Quarter 2026 Operating and Financial Results

Indeterminate GlobeNewswire

5 hours ago

AAVantgarde to present progress toward the first treatment for Usher syndrome type 1B at EYENOVATE and FLORetina 2026

Indeterminate GlobeNewswire

5 hours ago

TScan Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

5 hours ago

MediWound Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

5 hours ago

VETmAb Biosciences Appoints Katja Buhrer as Chief Operating Officer

Indeterminate GlobeNewswire

5 hours ago

Harrow to Participate in Two Investor Conferences in November

Indeterminate GlobeNewswire

5 hours ago

Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 Guidance

Indeterminate GlobeNewswire

5 hours ago

Satellos Reports Third Quarter 2026 Financial Results and Highlights Company Progress

Indeterminate GlobeNewswire

5 hours ago

Pelthos Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire